Mobile ODT / Apollo Hospitals

Results

• Over 700 patients were screened with the EVA system.
• The EVA System led to a suspected increase in the number of precancerous or cancerous cases detected at the primary screening where conventional Pap smears indicated a normal screening.
• Using the EVA System as a screening method, almost three times as many women were identified as having positive dysplasia in comparison to identification via a Pap smear. With EVA, these patients could be diagnosed and treated (or counseled) at the first visit, whereas a Pap smear would have missed these cases.
• High satisfaction: The EVA System scored either 4/5 or 5/5 on all measures of feasibility, usability, ease of training, patient satisfaction, and provider satisfaction with MobileODT support and engagement.
• When asked how using the EVA System influenced the way providers interact with patients, responses included: easy to describe abnormal images, it helped in explaining risks to patients, increased awareness, simplicity, and better patient understanding of the need for follow-up. 

Lessons Learned

• Both clinical and administrative decision makers focus on data proven technology adoption. Even if regulatory approval and non-inferiority trials exist, decision makers would not purchase devices without statistically significant data collected within India. 
• In India, a physical office with support staff is critical. Many decision makers will not purchase devices from a company without a physical presence in India, as customer support is a critical component of their purchasing decisions.